NEW YORK (360Dx) — OptraScan and Neuberg Diagnostics said on Tuesday that they have formed a new partnership that aims to bring OptraScan's digital pathology and telepathology services to Neuberg's histology network in India, the Middle East, and Africa.
The two parties have also launched OptraScan's Global TelePath Network in the United Arab Emirates, India, and South Africa under the partnership, which they have named Neuberg Digipath, Powered by OptraScan.
The partnership "combines the advanced digital pathology capabilities offered by OptraScan and the exceptional histopathology and cytology services provided by Neuberg Diagnostics to provide advanced and affordable digital pathology products in India, [the] Middle East, Africa, and beyond," Abhi Gholap, OptraScan's founder and CEO, said in a statement. He added that OptraScan’s Global TelePath Network has achieved traction in the US and Europe and today's deal is "part of our global strategy to create innovative healthcare affiliations with leading healthcare providers around the globe to enhance our reach in untapped regions."
"With OptraScan’s expertise in providing new-age technolog[ies] that are well-equipped with AI- and ML-based analysis tools, the newly combined collaboration will enable us to expand the service as well as the geographic reach of Neuberg's existing lab services. We expect the economies of scale from this partnership to help us bring better value to our clients and expand our service offerings," said GSK Velu, founder and chairman of Neuberg Diagnostics.
Financial and other terms of the agreement were not disclosed.